DIP2C: A Potential Drug Target and Biomarker (G22982)

Target Name: DIP2C

NCBI ID: G22982

DIP2C

DIP2C: A Potential Drug Target and Biomarker

Drug resistance is a major issue in healthcare, and researchers are constantly searching for new ways to combat it. One potential solution is to target DIP2C, a protein that has been identified as a drug target and biomarker for various diseases, including cancer, heart disease , and diabetes.

DIP2C is a protein that is expressed in various tissues throughout the body, including the brain, heart, and blood vessels. It is a member of the DIP2 family, which includes several related proteins that are involved in cell signaling. One of the most interesting of these proteins is DIP2C, which is known for its role in the regulation of angiogenesis, the formation of new blood vessels.

Recent studies have suggested that DIP2C may be a drug target for several diseases, including cancer, heart disease, and diabetes. For example, studies have shown that inhibiting DIP2C may have anti-tumor effects, and that targeting DIP2C may be a promising strategy for treating diabetes.

In addition to its potential therapeutic uses, DIP2C is also a potential biomarker for several diseases. The DIP2C protein is expressed in a variety of tissues and has been shown to be involved in several cellular processes, including cell signaling, angiogenesis, and inflammation. This makes it an attractive target for researchers who are looking for new diagnostic tools or targets for diseases.

One of the key challenges in studying DIP2C is its complex structure. Despite its importance, little is known about the precise structure and function of DIP2C. Researchers have identified several potential binding sites on DIP2C and are working to determine the most critical regions of the protein . This information will be important for developing new drugs and other therapies that target DIP2C.

In addition to its potential therapeutic and diagnostic uses, DIP2C is also a potential target for drug development. Researchers are exploring new small molecules and other compounds that can interact with DIP2C and enhance its effects. This may lead to the development of new treatments for a variety of diseases.

Overall, DIP2C is a protein that has great potential as a drug target and biomarker. Its structure and function continue to be explored by researchers, and its potential therapeutic and diagnostic uses continue to be investigated. As research continues, it is likely that DIP2C will become an increasingly important protein in the fight against disease.

Protein Name: Disco Interacting Protein 2 Homolog C

The "DIP2C Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about DIP2C comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets